The p53 pathway: targets for the development of novel cancer therapeutics.
Wang
Shulin
S
Howard Hughes Medical Institute, Department of Medicine, University of Pennsylvania, Philadelphia, USA.
El-Deiry
Wafik S
WS
D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D015195:Drug Design; D015316:Genetic Therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction; D016159:Tumor Suppressor Protein p53 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D000970:Antineoplastic Agents; D016159:Tumor Suppressor Protein p53